During its third track, BioFIT 2016 will address the major challenges which are shaping innovation funding for life sciences, including:
- A case study of funding models for new ventures
- Dos and don’ts from experienced entrepreneurs
- A focus on the European seed capital market
- Tips and tricks from VC’s about Series A financing
This stimulating track will focus on transmitting knowledge and optimizing key experts’ skills and experience.
Discover the Track 3 speakers:
- Thierry Laugel, Managing Partner and chairman of the Management Board of Kurma Partners, FR
- Philippe Monteyne, VC partner, Fund+, NL
- Michèle Ollier, Co-founder and partner, Medicxi Ventures, CH,
- Sam Fazeli, Head of Bloomberg Intelligence, EMEA; Senior Pharmaceutical Analyst – Bloomberg, UK,
- Jasper Bos, Vice President and Head of Healthcare, Merck Ventures, CH
- Daniel Green, CEO, Yaqrit, UK,
- Charles Woler, CEO of Biomnis, FR
